Pannu Geraldine
Insider CIK 1817209 · RBB Director · PCSA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PCSA Processa Pharmaceuticals, | A Award deriv | 2026-07-26 | 2026-07-28 | 33,500 | — | $0 | 38,749 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2026-07-26 | 2026-07-28 | 33,500 | — | $0 | 38,749 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise deriv | 2026-06-26 | 2026-06-30 | 203 | — | $0 | 5,249 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise | 2026-06-26 | 2026-06-30 | 203 | — | $0 | 2,391 | SEC↗ |
| RBB RBB Bancorp | M Exercise deriv | 2026-05-21 | 2026-05-26 | 700 | — | $0 | 0 | SEC↗ |
| RBB RBB Bancorp | A Award deriv | 2026-05-21 | 2026-05-26 | 2,546 | — | $0 | 2,546 | SEC↗ |
| RBB RBB Bancorp | M Exercise deriv | 2026-05-21 | 2026-05-26 | 1,846 | — | $0 | 700 | SEC↗ |
| RBB RBB Bancorp | M Exercise | 2026-05-21 | 2026-05-26 | 1,846 | — | $0 | 8,267 | SEC↗ |
| RBB RBB Bancorp | M Exercise | 2026-05-21 | 2026-05-26 | 700 | — | $0 | 6,421 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2026-03-31 | 2026-04-01 | 2,072 | $2.54 | $5.3K | 2,188 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2025-10-01 | 2025-10-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2025-10-01 | 2025-10-03 | 300,000 | — | $0 | 300,000 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2025-07-24 | 2025-07-28 | 175,299 | — | $0 | 206,505 | SEC↗ |
| RBB RBB Bancorp | M Exercise deriv | 2025-05-21 | 2025-05-22 | 2,821 | — | $0 | 700 | SEC↗ |
| RBB RBB Bancorp | M Exercise | 2025-05-21 | 2025-05-22 | 2,821 | — | $0 | 5,721 | SEC↗ |
| RBB RBB Bancorp | M Exercise deriv | 2025-05-15 | 2025-05-16 | 700 | — | $0 | 0 | SEC↗ |
| RBB RBB Bancorp | M Exercise | 2025-05-15 | 2025-05-16 | 700 | — | $0 | 2,900 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2024-09-03 | 2025-09-18 | 31,206 | — | $0 | 36,275 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2024-09-03 | 2024-09-18 | 31,206 | — | $0 | 31,206 | SEC↗ |
| RBB RBB Bancorp | M Exercise deriv | 2024-05-16 | 2024-05-17 | 800 | — | $0 | 700 | SEC↗ |
| RBB RBB Bancorp | M Exercise | 2024-05-16 | 2024-05-17 | 800 | — | $0 | 2,200 | SEC↗ |
| RBB RBB Bancorp | M Exercise deriv | 2024-01-18 | 2024-01-19 | 600 | — | $0 | 0 | SEC↗ |
| RBB RBB Bancorp | M Exercise | 2024-01-18 | 2024-01-19 | 600 | — | $0 | 1,400 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award | 2023-10-10 | 2023-10-10 | 4,500 | $0.21 | $945 | 57,613 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2023-06-27 | 2023-07-24 | 101,365 | — | $0 | 101,365 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise deriv | 2023-06-27 | 2023-07-24 | 23,636 | — | $0 | 0 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise | 2023-06-27 | 2023-07-24 | 23,636 | — | $0 | 53,113 | SEC↗ |
| RBB RBB Bancorp | M Exercise deriv | 2023-01-18 | 2023-01-20 | 800 | — | $0 | 600 | SEC↗ |
| RBB RBB Bancorp | M Exercise | 2023-01-18 | 2023-01-20 | 800 | — | $0 | 800 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2023-01-01 | 2023-01-04 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise | 2022-12-31 | 2023-01-04 | 18,208 | — | $0 | 29,477 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise | 2022-08-05 | 2022-08-09 | 1,169 | — | $0 | 11,269 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award | 2022-03-31 | 2022-04-04 | 4,393 | — | $0 | 10,100 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2022-01-01 | 2022-04-19 | 18,208 | — | $0 | 19,377 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award | 2021-08-05 | 2021-08-09 | 1,169 | — | $0 | 5,707 | SEC↗ |